Suppr超能文献

Rho激酶信号通路调控血管紧张素II诱导的肾损伤。

The Rho-kinase pathway regulates angiotensin II-induced renal damage.

作者信息

Rupérez Mónica, Sánchez-López Elsa, Blanco-Colio Luis Miguel, Esteban Vanesa, Rodríguez-Vita Juan, Plaza Juan José, Egido Jesús, Ruiz-Ortega Marta

机构信息

Vascular and Renal Research Laboratory, Fundación Jiménez Diaz, Universidad Autónoma, Madrid, Spain.

出版信息

Kidney Int Suppl. 2005 Dec(99):S39-45. doi: 10.1111/j.1523-1755.2005.09908.x.

Abstract

BACKGROUND

Angiotensin II (AngII) is a key factor in the pathogenesis of renal damage. AngII via AngII type 1 receptors activates several intracellular signaling systems, including the small guanosine triphosphatase Rho and its downstream effector Rho-dependent serine-threonine kinase (Rho-kinase). The Rho/Rho-kinase pathway contributes to inflammatory and proliferative changes observed in cardiovascular diseases. However, the data on renal diseases are scarce. The aim of this study was to investigate the effect of Rho-kinase inhibition in AngII-induced renal damage.

METHODS

We used the model of systemic AngII infusion into normal rats (100 ng/kg per minute; subcutaneous osmotic minipumps), and some animals were treated with the Rho-kinase inhibitor Y-27632 (30 mg/kg per day). In the kidneys of these animals, we evaluated renal lesions, transcription factor activity (by electrophoretic mobility shift assay), and messenger RNA (by polymerase chain reaction) and protein expression levels (by Western blot and/or immunohistochemistry) of proinflammatory and profibrotic factors.

RESULTS

Rats infused with AngII for three days present renal inflammatory cell infiltration and slight tubular damage, which were diminished by treatment with the Rho-kinase inhibitor Y-27632. AngII activates nuclear factor-kappaB and causes overexpression of proinflammatory factors, including cytokines (tumor necrosis factor alpha) and chemokines (monocyte chemotactic protein-1), and of profibrotic factors (connective tissue growth factor). Treatment of AngII-infused rats with Y-27632 decreases the upregulation of these proinflammatory and profibrotic mediators.

CONCLUSION

These data demonstrate that the Rho-kinase pathway is involved in renal damage caused by AngII through the regulation of proinflammatory and profibrotic mediators. These results suggest that inhibition of the Rho-kinase pathway represents a novel therapy for renal diseases associated with local AngII generation.

摘要

背景

血管紧张素II(AngII)是肾损伤发病机制中的关键因素。AngII通过1型血管紧张素II受体激活多种细胞内信号系统,包括小GTP酶Rho及其下游效应物Rho依赖性丝氨酸 - 苏氨酸激酶(Rho激酶)。Rho/Rho激酶途径促成了心血管疾病中观察到的炎症和增殖性变化。然而,关于肾脏疾病的数据却很少。本研究的目的是探讨Rho激酶抑制在AngII诱导的肾损伤中的作用。

方法

我们采用向正常大鼠皮下输注AngII(100 ng/kg每分钟;皮下渗透微型泵)的模型,部分动物用Rho激酶抑制剂Y-27632(30 mg/kg每天)进行治疗。在这些动物的肾脏中,我们评估了肾损伤、转录因子活性(通过电泳迁移率变动分析)、信使核糖核酸(通过聚合酶链反应)以及促炎和促纤维化因子的蛋白质表达水平(通过蛋白质免疫印迹法和/或免疫组织化学法)。

结果

输注AngII三天的大鼠出现肾炎症细胞浸润和轻微的肾小管损伤,用Rho激酶抑制剂Y-27632治疗可减轻这些损伤。AngII激活核因子-κB并导致促炎因子(包括细胞因子(肿瘤坏死因子α)和趋化因子(单核细胞趋化蛋白-1))以及促纤维化因子(结缔组织生长因子)的过度表达。用Y-27632治疗输注AngII的大鼠可降低这些促炎和促纤维化介质的上调。

结论

这些数据表明,Rho激酶途径通过调节促炎和促纤维化介质参与了AngII引起的肾损伤。这些结果提示,抑制Rho激酶途径代表了一种针对与局部AngII生成相关的肾脏疾病的新疗法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验